Loading...
How senior housing & care operators are navigating AI purchasing in a platform-anchored market — and where the acute-care playbook holds, bends, and breaks.
In July 2026, Redesign Health published a landmark survey of 112 senior executives at Epic-based health systems. The findings were unambiguous: 71% of health systems call themselves "Epic-first," 91% express complete or significant confidence in Epic's AI roadmap, and yet 64% remain likely to buy from a net-new startup — provided it integrates easily, proves ROI fast, and competes where the platform is structurally weakest.
This report asks the question that survey makes urgent for our sector: does the same gravity govern senior housing & care, where a single incumbent platform anchors most of the skilled nursing clinical record? The honest answer is: partly — and the places where it doesn't are where the next decade of value will be built.
1. The anchor is real — but it is partial. A single platform's dominance of the skilled nursing record is the closest thing this sector has to the Epic effect. But acute care consolidates to one platform across the enterprise; senior housing & care runs an EHR beside a separate general ledger, a separate payroll and scheduling system, a separate CRM, and a capital partner's reporting stack. There is no Epic of senior housing & care — and the market's structure suggests there may never be one.
2. The confidence question transfers. In the twelve months to August 2026, the sector's incumbent platforms shipped or announced AI workflow suites, native ambient documentation, and next-generation practitioner EHRs. The pitch "the incumbent won't get this right" is as dead in senior housing & care as the acute-care data shows it is in hospitals.
3. The open ground is above and between systems. Acute-care buyers say external vendors win in areas that require coordination beyond the platform, that the incumbent historically de-emphasized, or that face outward. Translated to this sector, that describes the layer no incumbent owns: governance across the EHR, the ledger, the labor system, and the capital relationship.
The implication for operators, founders, and investors: the acute-care window is narrowing inside the platform's walls and staying open at its edges. In senior housing & care, the walls cover less of the building. This report maps the difference — and closes with the survey, now moving to field, that will replace its hypotheses with operator data.
Redesign Health's report draws its authority from primary data. This report does not yet have operator survey data behind it — and it does not pretend to. Every claim in the pages that follow is written in one of three registers, labeled at every use:
BenchmarkFindings from Redesign Health's The Epic Effect (fielded October 2025 – March 2026; n = 112 qualified executives at Epic-based U.S. health systems), cited as the acute-care reference point. These are their data, attributed throughout.
TranslationVerified public facts about the senior housing & care market — platform footprints, product announcements, and independent analyses, described in general terms without naming vendors — plus structural analysis of how this sector's buyer, stack, and capital dynamics differ from acute care. Vendor-published figures are labeled as such at every occurrence.
HypothesisStatements about what senior housing & care operators believe or will do. These are testable predictions, numbered H1–H13, not findings. The companion survey in the final section is built to confirm or kill each one, and is moving to field for October–December 2026. Where the acute-care study reports what executives said, this report states what we expect operator data to show — and invites the sector to prove us wrong.
This analysis is independent, and it names no senior housing & care platform vendor. SeniorCRE is not affiliated with, endorsed by, or connected to Redesign Health. All third-party figures are drawn from publicly available materials as of August 2026 and attributed in the source register at the end of this report.
The Redesign Health data describes a market with a center of gravity: 71% of health systems call themselves "Epic-first," prioritizing Epic modules whenever possible, and not one respondent prefers external vendors by default. Roughly 60% of clinical and administrative IS budgets flow to Epic. Seventy percent report leaning further into Epic over the past three to five years; 80% expect the lean to steepen. In acute care, a startup is pitching a buyer who expects the platform to win.
Translation · senior housing & careThe nearest analog in this sector is unambiguous in structure. A single vendor anchors the clinical record across most of U.S. skilled nursing: third-party analyses attribute roughly 60% of that EHR market to the leading platform [4], which pairs a footprint of tens of thousands of provider organizations with a marketplace of hundreds of integration partners and years of top industry-satisfaction rankings (vendor-published and third-party materials) [5]. Inside the skilled nursing facility, the clinical record has a home, and the home has an owner.
But here the analogy stops carrying the whole weight — for three structural reasons:
An Epic health system can run clinical, revenue cycle, patient access, and analytics on one platform. A senior housing & care operator cannot. The EHR sits beside a separate accounts-receivable and general-ledger system, a separate payroll and scheduling stack, a separate sales CRM, and — for most of the industry — a capital partner's reporting requirements that none of those systems were built to serve. The question acute care asks ("why not just use Epic's module?") has no equivalent here, because no single vendor fields a module for the whole stack.
The anchor platform's dominance is concentrated in skilled nursing. Across assisted living, memory care, and independent living, the record is split among many vendors — a genuinely fragmented, multi-vendor landscape with no consolidating force comparable to Epic's march through hospital systems. An operator with a portfolio spanning acuity levels is often running different systems of record building by building.
Acute-care purchasing runs through CIO organizations with formal committees. In senior housing & care, many operators have no CIO at all; purchasing authority sits with the COO, CFO, and regional operations leaders — and, for a large share of the industry, the owner or capital partner holds real influence over what the operator deploys. The gravitational field exists, but it bends around a different mass.
Among skilled-nursing-led operators, a majority will describe themselves as incumbent-first for clinical modules — directionally mirroring the 71% Epic-first finding.
Among assisted living and independent living operators, no single vendor will command an equivalent "default first" position; stated purchasing philosophy will skew best-in-breed.
The operator technology budget will show a more fragmented split than acute care's 60/40 — with the EHR taking a materially smaller share of total software spend than Epic takes of hospital IS budgets.
One of the Redesign study's most actionable findings is structural: 43% of health system executives say AI purchases land first in department or service-line budgets before migrating to central IT, another 33% expect them to stay departmental permanently, and 52% report that department leaders hold full purchasing autonomy — tempered by AI governance committees that review everything anyway. The startup window opens before AI purchasing centralizes.
Translation · senior housing & careThis sector's version of that finding is more extreme in both directions. On one side, there is often no central IT function for AI budgets to migrate to: purchasing already lives with the COO, the CFO, and executive directors, which means the decentralized window acute-care startups are racing to exploit is, here, simply how the market works. On the other side, the thin IT bench cuts against the buyer too — there is no internal integration team to absorb a difficult deployment, so implementation burden transfers entirely to the vendor, and a hard-to-deploy product dies faster here than in a hospital.
Two additional forces have no acute-care equivalent. First, the capital relationship: in large parts of the industry, owners, REITs, and private equity sponsors shape operator technology decisions through reporting requirements, capex approval, and portfolio standardization. Second, AI governance is arriving unevenly — larger operators are beginning to stand up review processes for clinical AI, while smaller operators buy on trust and references.
The GTM surface acute-care startups are discovering — the service-line buyer with budget autonomy — is the native terrain of senior housing & care. The trade: you inherit the whole integration burden, and you may be selling to a triangle of operator, owner, and lender rather than a single decision maker.
Purchasing authority for AI solutions will concentrate with COO/CFO/operations leadership rather than IT — at a higher rate than acute care's 52% departmental autonomy.
A material share of operators will report that owners or capital partners influence — or in some structures effectively decide — major system selections.
Epic's 2025 User Group Meeting moved its market: 66% of surveyed executives reported increased interest in Epic solutions afterward, and 91% expressed complete or significant confidence that Epic's AI will match best-in-class external vendors. The Redesign authors draw the conclusion every founder should memorize: the pitch "the incumbent won't get this right" is dead on arrival with sophisticated buyers.
Translation · senior housing & careAnyone tempted to assume the sector's incumbents are standing still should read twelve months of announcements. Between mid-2025 and August 2026, the leading platforms shipped or announced, in public materials [5]: AI-native workflow suites spanning chart review, referral intake, and billing; ambient, voice-enabled documentation built natively into the EHR; next-generation, ONC-certified practitioner EHRs with embedded AI; refreshed platform experiences beyond skilled nursing; and membership in national health-AI governance coalitions.
The pattern rhymes with Epic's almost exactly — including the most pointed parallel. In the acute-care data, ambient documentation tops the list of areas where executives think startups can compete (48%) even though Epic just announced a native scribe. Senior housing & care now has its own version of that collision: a field of third-party documentation tools, and native ambient products shipping from the platforms themselves. How that contest resolves will be the sector's clearest early signal of whether the acute-care pattern transfers.
One asymmetry deserves honest treatment. The leading platforms describe their long-term and post-acute care datasets as the industry's deepest (vendor-published), and their AI cadence to date concentrates where that data is deepest: skilled nursing clinical and billing workflows. The announcements say much less about the layer above the EHR — cross-system governance, labor economics, and the operator-to-capital reporting chain. Confidence, as the Redesign authors note, is not the same as believing the incumbent wins everywhere.
Hypotheses · to be testedA majority of skilled-nursing operators will express high confidence in their incumbent platform's ability to execute its AI roadmap within its core clinical domain — directionally echoing the 91% acute-care figure.
Confidence will fall measurably for domains above the EHR: cross-system data governance, labor and margin analytics, and capital-partner reporting.
Asked to rate 17 functional areas on a 1–5 scale for external-vendor opportunity, Redesign's respondents produced a narrow band (means of 3.16 to 3.52) with a sharp underlying logic. External vendors are seen as most competitive where the work (i) requires coordination beyond the platform's walls, (ii) sits in domains the incumbent historically de-emphasized, or (iii) faces outward toward patients and partners. The incumbent is strongest where its data position and workflow embedment compound — bed management, interoperability, clinical decision support.
Translation · senior housing & careRather than invent survey means, this report applies those three criteria to the functional areas of senior housing & care and states a structural read for each. Anchor advantage marks ground where the incumbent's data position compounds; Contested marks live collisions between the platform's roadmap and external vendors; Open ground marks work that is cross-system, cross-organization, or historically unclaimed. These are analytical judgments — the survey instrument in the final section converts each row into a ratable question.
| Functional area | Structural read | Rationale against the three acute-care criteria |
|---|---|---|
| Medication administration (eMAR) & clinical documentation | Anchor advantage | The incumbent's deepest data position and workflow embedment; the acute-care analog is clinical decision support, rated hardest to displace. |
| MDS / PDPM & reimbursement coding | Anchor advantage | Regulatory workflow fused to the clinical record; platform advantage compounds with every rule change. |
| Referral intake & admissions | Anchor advantage | Incumbent AI investment has concentrated here; network position on both sides of the referral strengthens the platform. |
| Ambient & voice documentation | Contested | The sector's version of the acute-care scribe collision: native platform products now entering the market against a field of specialists. Watch this space first. |
| Billing, collections & revenue cycle AI | Contested | Native platform billing AI is arriving; but payer-mix complexity and multi-system AR keep specialist room open — revenue cycle rated 3.44 in the acute-care data. |
| Census, sales CRM & marketing | Contested | Outward-facing (criterion iii) and historically multi-vendor; incumbent investment is real but not dominant outside skilled nursing. |
| Survey readiness & compliance operations | Contested | Documentation-adjacent (favors the platform) but spans systems and human process (favors specialists). |
| Labor: scheduling, agency spend & acuity-based staffing | Open ground | Requires coordination across payroll, scheduling, agency vendors, and the clinical record — squarely criterion (i). No system of record owns the full loop. |
| Family & resident engagement | Open ground | The sector's patient-facing surface — the acute-care data puts patient-facing AI near the top of startup opportunity (40%). |
| Discharge, transitions & network coordination | Open ground | Inherently cross-organization; the acute-care analog (discharge & care transitions, mean 3.51) ranked among the most contestable areas. |
| Cross-system data governance, lineage & record authority | Open ground | The work of reconciling EHR, ledger, labor, and CRM into one governed operating picture belongs to no incumbent; it is above every system of record by definition. |
| Operator-to-capital reporting (owner, REIT, lender) | Open ground | Requires coordination with external organizations that clinical platforms were never built to serve — criterion (i) in its purest sectoral form. |
Structural reads are SeniorCRE's analytical judgments applied against the three criteria surfaced by the acute-care benchmark; they are not survey results. Incumbent product references reflect publicly available vendor announcements as of August 2026 [5].
Operators will rate external-vendor opportunity lowest in eMAR, MDS/PDPM, and referral intake — the anchor's compounding core.
Operators will rate opportunity highest in labor economics, cross-system governance, and capital reporting — the areas no system of record owns.
Ambient documentation will top the startup-opportunity list even after the native product ships — mirroring the acute-care result (48% despite Epic's announcement).
The acute-care numbers are blunt: 49% of executives require external vendors to demonstrate significantly higher ROI than the incumbent's offering, and another 29% require somewhat higher — only 18% apply the same bar to both. When executives explain why the incumbent wins, "good enough" capability (48%) plus lower deployment friction (50%) plus total-cost efficiency (47%) form a self-reinforcing loop. And when external vendors do win, they win on ease of integration (in 63% of top-four rankings), faster time to value (59%), and proven outcomes.
Translation · senior housing & careThree sector-specific facts sharpen that bar rather than soften it.
The ROI denominator is NOI. Hospital AI sells on clinical quality, throughput, and reimbursement. Senior housing & care runs on a property P&L: occupancy, labor cost, agency dependence, collections, compliance exposure. An external vendor's ROI story here must survive an operator's margin math and an owner's asset math — because in much of the industry, both parties read the same statement. Vendors who can express value in occupied units, agency hours eliminated, and margin per community speak the native language; vendors who can't are asking the buyer to translate.
"Good enough" weighs more when the IT bench is thin. The acute-care "good enough" signal — nearly half of executives accepting the incumbent's lower capability bar to avoid deployment friction — should be expected to run stronger here, because the operator absorbing that friction has no integration team to spend. The counterweight: every point of friction a vendor removes converts directly into competitive position, which is why ease of integration is not a feature in this sector. It is the qualifying round.
Proof beats roadmap. A market that has watched technology promises come and go prices demonstrated outcomes over projected ones. The acute-care finding that co-development arrangements hold little premium over product quality (design-partner receptivity of 62%, barely distinct from net-new startups at 64%) suggests the same discipline: buyers want the thing to work, measurably, quickly.
A majority of operators will require higher demonstrated ROI from external vendors than from incumbent modules — at or above the acute-care combined rate of 78%.
Occupancy, labor cost, and collections will outrank clinical-quality metrics as the ROI measures operators require external AI vendors to prove.
The Redesign study's most encouraging finding for founders: 64% of health system executives are likely or very likely to purchase from a net-new startup with three or fewer live customers — only 12 points behind established incumbents at 76%. The startup discount, in the buyer's own stated intent, is smaller than the market assumes.
Translation · senior housing & careSenior housing & care has bought from small vendors for decades — the sector's point-solution landscape exists precisely because operators routinely purchase from young, focused companies. Stated receptivity here should meet or beat the acute-care figure for operational tools. Two forces complicate the picture as AI reaches deeper into the building:
The trust floor is rising. The moment a product touches resident records, medication data, or staff PHI, the evaluation changes character: business associate agreements, security posture, and clinical-safety governance stop being paperwork and become the substance of the decision. Operators — and the capital partners behind them — are learning to ask harder questions of clinical-adjacent AI than they ever asked of point solutions.
References carry more weight in a small world. The sector's operator community is tightly networked; a handful of named, verifiable deployments moves this market more than any volume of marketing. The acute-care finding that co-development arrangements add little premium likely holds here too — with the caveat that the first few production references are worth disproportionately more in a market this relational.
Hypotheses · to be testedStartup receptivity will meet or exceed the 64% acute-care benchmark for operational and financial tools — and fall measurably below it for products that touch the clinical record, where security and clinical-safety posture become gating criteria.
The acute-care data carries a warning worth importing whole: platform gravity is comfortable, and comfort compounds. Before the next system decision — incumbent module or external vendor alike — the questions that protect an operator's position are governance questions. Who owns the record this system creates? What are the export rights, in what formats, on what timeline, at what cost? When two systems disagree about the same resident, the same shift, the same dollar, whose rule decides which number governs? What does the exit look like? Operators who put those answers in writing before signing keep their options; operators who don't discover the price of the default years later.
Pick your ground against the structure, not the incumbent. The acute-care lesson — the difference between a 44% category and a 4% category is the difference between a market and a wall — translates directly: building inside the anchor's compounding core (the medication record, MDS, referral intake) means fighting the platform where its data advantage grows daily, while building in the open ground (labor economics, cross-system governance, capital reporting, family engagement) means competing where no system of record holds the terrain. Make ease of integration the product's first feature, not its roadmap item; in a sector without IT departments, deployment friction is destiny. Denominate every ROI claim in NOI. And retire the "incumbent can't build AI" pitch — twelve months of shipped announcements say otherwise, and buyers know it.
The conviction framework from the acute-care report — back categories that score high on both general contestability and startup-specific opportunity — maps onto this sector's structure rather than its survey means, for now. Highest structural conviction: the cross-system layer (labor, governance, capital reporting) where fragmentation is permanent and no incumbent roadmap reaches. Moderate: outward-facing surfaces (engagement, transitions, census) where incumbent investment is real but contested. Lowest: anything whose value depends on displacing the skilled nursing clinical record head-on. The companion survey will replace this structural ranking with operator data; until then, treat the acute-care pattern as the prior, not the answer.
Acute care has no analog for the sector's most distinctive buyer dynamic: owners, REITs, and lenders whose reporting needs shape operator technology from outside the building. As AI purchasing accelerates at the operator level, capital partners face a choice the acute-care CIO never did — set data and governance expectations for the portfolio deliberately, or inherit whatever fragmented picture the building-by-building decisions produce. The partners who write data rights, export standards, and reporting definitions into their operator relationships will hold a clearer view of their own assets than those who leave it to default.
Every hypothesis in this report is falsifiable, and this is the instrument built to test them — adapted question-for-question from the acute-care benchmark so the two markets can be read side by side. The study fields October–December 2026 with a neutral co-fielding partner; operator executives who participate receive the benchmark report before public release, and a donation is made to a sector charity of their choice for each completed response. Respondent data is reported only in aggregate, and respondent lists are never used for sales outreach.
Which best describes your role? (CEO / COO / CFO / Chief Clinical or Nursing Officer / Regional or VP Operations / IT leadership / Owner or capital partner)
How many communities does your organization operate, and across which settings? (Skilled nursing / assisted living / memory care / independent living / CCRC)
What is your role in purchasing decisions for clinical and operational systems? (Final decision maker / formal evaluator / influencer / not involved)
Which systems of record does your organization run today? (Clinical EHR/eMAR; AR & general ledger; payroll & scheduling; sales CRM; other — name each vendor)
Tests the plural-stack premise underlying H1–H3.
Which statement best describes your purchasing philosophy today for new clinical and operational solutions?
How has that philosophy changed over the past 3–5 years, and how do you expect it to evolve over the next 3–5?
Approximately what share of your technology budget goes to your primary EHR vendor versus all other software vendors combined?
Where do new AI solution purchases land in your organization? (Community/regional budgets first; corporate operations; finance; IT; owner/capital-partner driven) Who holds final authority?
To what extent do owners, REITs, or capital partners influence your major system selections? (1 = not at all, 5 = they effectively decide)
No acute-care equivalent; tests H5.
How confident are you that your primary EHR vendor will execute on its AI roadmap in a way that matches best-in-class external solutions — (a) within clinical documentation and billing, and (b) in domains above the EHR such as labor analytics, cross-system reporting, and capital reporting? (Complete / significant / somewhat / little confidence, rated separately)
The two-part structure tests H6 against H7.
On a 1–5 scale, how likely is it that an external vendor of any kind can compete against your primary EHR vendor's current and announced solutions in each of the following areas: eMAR & clinical documentation; MDS/PDPM; referral & admissions; ambient documentation; billing & collections; census & CRM; survey readiness & compliance; labor scheduling & agency management; family & resident engagement; discharge & transitions; cross-system data governance; operator-to-capital reporting.
Converts the Section IV structural map into ratable rows; tests H8–H9.
From that same list, select the four areas where a new startup — not an established vendor — has the best opportunity to compete.
Tests H10.
Compared to solutions from your primary EHR vendor, what ROI must an external vendor demonstrate? (Significantly higher / somewhat higher / equivalent) And which measures count: occupancy, labor cost, agency hours, collections, compliance exposure, clinical quality, staff retention?
Tests H11–H12.
When you have chosen your primary EHR vendor's module over an external alternative, what were the reasons? (Integration; capability good enough; total cost; workflow simplicity; vendor consolidation; staff familiarity)
Rank your top four factors for when external vendors win: ease of integration; faster time to value; proven outcomes; specialized functionality; price; service; data portability and governance terms.
Rate 1–5 your likelihood of purchasing from: an established incumbent; a medium-sized vendor; a design-partner startup (≤3 live customers, co-building); a net-new startup — separately for (a) operational tools and (b) products touching the clinical record.
The (a)/(b) split tests H13.
Participate or co-field this research: Contact us
Findings publish in Q1 2027 as a co-branded companion report pairing operator data against the acute-care benchmark, with methodology, fielding dates, disclosed n, and confidence testing published in full. Participants receive the report first.